Found: 157
Select item for more details and to access through your institution.
Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 11, p. 2828, doi. 10.1093/jac/dkae293
- By:
- Publication type:
- Article
Comparing the frequency, antifungal susceptibility, and enzymatic profiles of the oral fungal composition in patients with and without Alzheimer's disease admitted to a neurology clinic.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1477230
- By:
- Publication type:
- Article
An in-vitro comparative study of the binding of caspofungin and micafungin to plasma proteins.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 1, p. 88, doi. 10.1093/jpp/rgab157
- By:
- Publication type:
- Article
Detection, Screening, and Antifungal Susceptibility of the Current Threat Candida auris: A Tertiary Hospital Experience.
- Published in:
- Haydarpasa Numune Medical Journal, 2023, v. 63, n. 4, p. 405, doi. 10.14744/hnhj.2023.92653
- By:
- Publication type:
- Article
Prevalence and Antifungal Susceptibility of Vulvovaginal Candidiasis in Female Genital Tract.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 1397, doi. 10.31838/ijpr/2021.13.01.305
- By:
- Publication type:
- Article
Antifungals influence the immune-related transcriptomic landscape of human monocytes after Aspergillus fumigatus infection.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08738-4
- By:
- Publication type:
- Article
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 3, p. 1149, doi. 10.1007/s40121-022-00625-9
- By:
- Publication type:
- Article
No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 1, p. 543, doi. 10.1007/s40121-021-00586-5
- By:
- Publication type:
- Article
Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.891336
- By:
- Publication type:
- Article
Ketoconazole induces reversible antifungal drug tolerance mediated by trisomy of chromosome R in Candida albicans.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1450557
- By:
- Publication type:
- Article
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 4, p. 417, doi. 10.1093/jpids/piaa119
- By:
- Publication type:
- Article
A six-year hospital-based surveillance study on burden of esophageal candidiasis in Gangtok, Sikkim.
- Published in:
- Iranian Journal of Microbiology, 2022, v. 14, n. 4, p. 598
- By:
- Publication type:
- Article
Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102161
- By:
- Publication type:
- Article
In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against Candida auris.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 9, p. 1333, doi. 10.3390/pharmaceutics13091333
- By:
- Publication type:
- Article
Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 504, doi. 10.3390/pharmaceutics13040504
- By:
- Publication type:
- Article
Simultaneous Quantification of Seven Antifungal Agents in Human Serum Using Liquid Chromatography-Tandem Mass Spectrometry.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1537, doi. 10.3390/ph16111537
- By:
- Publication type:
- Article
Early Diagnosis of Fungal Sepsis in the Older persons Can Be Lifesaving - A Series of Three Cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Analysis of the Localization of Schizosaccharomyces pombe Glucan Synthases in the Presence of the Antifungal Agent Caspofungin.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4299, doi. 10.3390/ijms24054299
- By:
- Publication type:
- Article
A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09031-7
- By:
- Publication type:
- Article
Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08774-z
- By:
- Publication type:
- Article
Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08372-z
- By:
- Publication type:
- Article
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1012521
- By:
- Publication type:
- Article
Identification of Molecular and Genetic Resistance Mechanisms in a Candida auris Isolate in a Tertiary Care Center in Türkiye.
- Published in:
- Mycopathologia, 2023, v. 188, n. 6, p. 929, doi. 10.1007/s11046-023-00787-1
- By:
- Publication type:
- Article
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
- Published in:
- Mycopathologia, 2023, v. 188, n. 1/2, p. 111, doi. 10.1007/s11046-022-00688-9
- By:
- Publication type:
- Article
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
- Published in:
- Mycopathologia, 2023, v. 188, n. 1/2, p. 99, doi. 10.1007/s11046-022-00687-w
- By:
- Publication type:
- Article
Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.
- Published in:
- Mycopathologia, 2022, v. 187, n. 2/3, p. 217, doi. 10.1007/s11046-022-00616-x
- By:
- Publication type:
- Article
Resistance profiles to antifungal agents in Candida albicans isolated from human oral cavities: systematic review and meta-analysis.
- Published in:
- Clinical Oral Investigations, 2022, v. 26, n. 11, p. 6479, doi. 10.1007/s00784-022-04716-2
- By:
- Publication type:
- Article
Screening the Tocriscreen™ bioactive compound library in search for inhibitors of Candida biofilm formation.
- Published in:
- APMIS, 2022, v. 130, n. 9, p. 568, doi. 10.1111/apm.13260
- By:
- Publication type:
- Article
Optical Nanomotion Detection to Rapidly Discriminate between Fungicidal and Fungistatic Effects of Antifungals on Single-Cell Candida albicans.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 8, p. 712, doi. 10.3390/antibiotics13080712
- By:
- Publication type:
- Article
Fighting Emerging Caspofungin-Resistant Candida Species: Mitigating Fks 1-Mediated Resistance and Enhancing Caspofungin Efficacy by Chitosan.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 7, p. 578, doi. 10.3390/antibiotics13070578
- By:
- Publication type:
- Article
Multidisciplinary Approach in the Treatment of Descending Necrotizing Mediastinitis: Twenty-Year Single-Center Experience.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 5, p. 664, doi. 10.3390/antibiotics11050664
- By:
- Publication type:
- Article
Caspofungin-Induced Cardiotoxicity in Patients Treating for Candidemia.
- Published in:
- Toxics, 2022, v. 10, n. 9, p. 521, doi. 10.3390/toxics10090521
- By:
- Publication type:
- Article
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 5, p. 927, doi. 10.1007/s10096-024-04799-7
- By:
- Publication type:
- Article
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida : A European Study.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.906563
- By:
- Publication type:
- Article
An overview of opportunistic fungal infections associated with COVID-19.
- Published in:
- 3 Biotech, 2023, v. 13, n. 7, p. 1, doi. 10.1007/s13205-023-03648-2
- By:
- Publication type:
- Article
Phenomenon of Dip Effect in Antifungal Susceptibility Testing of Candida tropicalis by using MIC Testing Strips against Echinocandins.
- Published in:
- Journal of Clinical & Diagnostic Research, 2024, v. 18, n. 6, p. 1, doi. 10.7860/JCDR/2024/68810.19512
- By:
- Publication type:
- Article
Insight into advances for the biosynthetic progress of fermented echinocandins of antifungals.
- Published in:
- Microbial Biotechnology, 2024, v. 17, n. 1, p. 1, doi. 10.1111/1751-7915.14359
- By:
- Publication type:
- Article
Isolate distribution and antifungal susceptibility of Saccharomyces cerevisiae in the national regional medical center of Southwest China for women and children during 2018–2023.
- Published in:
- BMC Microbiology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12866-024-03506-y
- By:
- Publication type:
- Article
Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China.
- Published in:
- BMC Microbiology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12866-023-03105-3
- By:
- Publication type:
- Article
Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China.
- Published in:
- BMC Microbiology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12866-023-03105-3
- By:
- Publication type:
- Article
The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex.
- Published in:
- Lasers in Medical Science, 2022, v. 37, n. 3, p. 1651, doi. 10.1007/s10103-021-03415-w
- By:
- Publication type:
- Article
Safety and efficacy of non-reduced use of caspofungin in patients with Child–Pugh B or C cirrhosis: a real-world study.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 1063, doi. 10.1007/s15010-023-02162-0
- By:
- Publication type:
- Article
Caspofungin-Loaded Formulations for Treating Ocular Infections Caused by Candida spp.
- Published in:
- Gels (2310-2861), 2023, v. 9, n. 4, p. 348, doi. 10.3390/gels9040348
- By:
- Publication type:
- Article
Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features.
- Published in:
- Gels (2310-2861), 2023, v. 9, n. 4, p. 308, doi. 10.3390/gels9040308
- By:
- Publication type:
- Article
Effect of the 1064 nm Nd: YAG Laser on the MICs of Antifungals Used in Clinical Practice for the Treatment of Fungal Nail Infections.
- Published in:
- Journal of Lasers in Medical Sciences, 2023, v. 14, p. 1, doi. 10.34172/jlms.2023.35
- By:
- Publication type:
- Article
Multilocus Sequence Typing and Antifungal Susceptibility of Vaginal and Non-vaginal Candida glabrata Isolates From China.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.808890
- By:
- Publication type:
- Article
Hepatic safety of caspofungin during treatment of fungal diseases in neonates.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 11, p. 877, doi. 10.5246/jcps.2022.11.074
- By:
- Publication type:
- Article
In vitro antifungal activity of biosynthesized selenium nanoparticles using plant extracts and six comparators against clinical Fusarium strains.
- Published in:
- Current Medical Mycology, 2023, v. 9, n. 4, p. 17, doi. 10.22034/CMM.2024.345189.1504
- By:
- Publication type:
- Article
Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy.
- Published in:
- Current Medical Mycology, 2022, v. 8, n. 3, p. 18, doi. 10.18502/cmm.8.3.11210
- By:
- Publication type:
- Article